Late gastrointestinal toxicities following radiation therapy for prostate cancer

European Urology

Volumn 60, Issue 5, 2011, Pages 908-916

  Kim, Sung ^a,b,d   Shen, Shunhua ^a   Moore, Dirk F ^a,c   Shih, Weichung ^a,c   Lin, Yong ^a,c   Li, Hui ^a   Dolan, Matthew ^b   Shao, Yu Hsuan ^a   Lu Yao, Grace L ^a,b,d  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d Betty Gallo Prostate Cancer Center   (United States)

Author keywords

Late gastrointestinal toxicity; Medicare; Prostate cancer; Radiation therapy; Surveillance Epidemiology and End Results program

Indexed keywords

AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIGESTIVE SYSTEM FISTULA; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL OBSTRUCTION; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTESTINE ULCER; MAJOR CLINICAL STUDY; MALE; PHOTON THERAPY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION INJURY;

AGED; AGED, 80 AND OVER; GASTROINTESTINAL DISEASES; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM STAGING; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; TIME FACTORS; UNITED STATES;

EID: 80053311342     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.05.052     Document Type: Article

References (18)

1. A. Pollack, G. Zagars, and G. Starkschall Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105 (Pubitemid 34787842)
2. N. Stone, and R. Stock Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years Urology 69 2007 338 342 (Pubitemid 46274929)
3. J.L. Warren, C.N. Klabunde, D. Schrag, P.B. Bach, and G.F. Riley Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Med Care 40 2002 IV-3-18
4. G.S. Cooper, Z. Yuan, and K.C. Stange Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment Med Care 38 2000 411 421
5. E.B. Lamont, D.S. Lauderdale, R.L. Schilsky, and N.A. Christakis Construct validity of medicare chemotherapy claims: the case of 5FU Med Care 40 2002 201 211
6. G.S. Cooper, B. Virnig, and C.N. Klabunde Use of SEER-Medicare data for measuring cancer surgery Med Care 40 2002 IV-43-8
7. B.A. Virnig, J.L. Warren, and G.S. Cooper Studying radiation therapy using SEER-Medicare-linked data Med Care 40 2002 IV-49-54
8. Common Terminology Criteria for Adverse Events (CTCAE) v.4.0. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute Web site. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010- 06-14-QuickReference-5x7.pdf.
9. RTOG/EORTC late radiation morbidity scoring schema. Radiation Oncology Therapy Group Web site. http://www.rtog.org/ResearchAssociates/ AdverseEventReporting/RTOGEORTCLateRadiationMorbidityScoringSchema.aspx.
10. M.J. Zelefsky, S.A. Leibel, and P.B. Gaudin Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer Int J Radiat Oncol Biol Phys 41 1998 491 500 (Pubitemid 28275076)
11. V. Coviello, and M. Boggess Cumulative incidence estimation in the presence of competing risks Stata J 4 2004 103 112
12. H. Putter, M. Fiocco, and R.B. Geskus Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2007 2389 2430 (Pubitemid 46730255)
13. D.R. Cox, and D. Oakes Analysis of survival data 1984 Chapman and Hall New York, NY
14. Z. Alicikus, Y. Yamada, and Z. Zhang Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer Cancer 117 2011 1429 1437
15. D.Y. Gelblum, and L. Potters Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer Int J Radiat Oncol Biol Phys 48 2000 119 124 (Pubitemid 30488221)
16. J.D. Slater, C.J. Rossi, and L.T. Yonemoto Proton therapy for prostate cancer: the initial Loma Linda University experience Int J Radiat Oncol Biol Phys 59 2004 348 352 (Pubitemid 38622585)
17. Nihei K, Ogino T, Onozawa M, et al. Multi-institutional phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities. Int J Radiat Oncol Biol Phys. In press.
18. C.N. Klabunde, A.L. Potosky, J.M. Legler, and J.L. Warren Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267 (Pubitemid 32007842)